{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:07:35Z","timestamp":1782223655562,"version":"3.54.5"},"reference-count":27,"publisher":"Aging and Disease","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2024]]},"DOI":"10.14336\/ad.2024.0986","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T18:11:26Z","timestamp":1724868686000},"page":"1989","source":"Crossref","is-referenced-by-count":7,"title":["Genetic Risk, Inflammation, and Therapeutics: An Editorial Overview of Recent Advances in Aging Brains and Neurodegeneration"],"prefix":"10.14336","volume":"15","author":[{"given":"Vivek","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Chitranshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veer Bala","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2024.0986-1","doi-asserted-by":"crossref","unstructured":"Sobue A, Komine O, Yamanaka K (2023). Neuroinflammation in Alzheimer\u2019s disease: microglial signature and their relevance to disease. Inflammation and Regeneration, 43:26.","DOI":"10.1186\/s41232-023-00277-3"},{"key":"key-10.14336\/AD.2024.0986-2","doi-asserted-by":"crossref","unstructured":"Basavarajappa D, Gupta V, Chitranshi N, Viswanathan D, Gupta V, Vander Wall R, et al. (2023). Anti-inflammatory effects of siponimod in a mouse model of excitotoxicity-induced retinal injury. Molecular Neurobiology, 60:7222-7237.","DOI":"10.1007\/s12035-023-03535-0"},{"key":"key-10.14336\/AD.2024.0986-3","doi-asserted-by":"crossref","unstructured":"Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM (2021). Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Progress in retinal and eye research, 83:100916.","DOI":"10.1016\/j.preteyeres.2020.100916"},{"key":"key-10.14336\/AD.2024.0986-4","doi-asserted-by":"crossref","unstructured":"Kung H-C, Lin K-J, Kung C-T, Lin T-K (2021). Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease. Biomedicines, 9:918.","DOI":"10.3390\/biomedicines9080918"},{"key":"key-10.14336\/AD.2024.0986-5","doi-asserted-by":"crossref","unstructured":"Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, et al. (2021). Retinal changes in Alzheimer's disease\u2014integrated prospects of imaging, functional and molecular advances. Progress in retinal and eye research, 82:100899.","DOI":"10.1016\/j.preteyeres.2020.100899"},{"key":"key-10.14336\/AD.2024.0986-6","doi-asserted-by":"crossref","unstructured":"Cai Q, Jeong YY (2020). Mitophagy in Alzheimer\u2019s disease and other age-related neurodegenerative diseases. Cells, 9:150.","DOI":"10.3390\/cells9010150"},{"key":"key-10.14336\/AD.2024.0986-7","doi-asserted-by":"crossref","unstructured":"Gandhi J, Antonelli AC, Afridi A, Vatsia S, Joshi G, Romanov V, et al. (2019). Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics. Rev Neurosci, 30:339-358.","DOI":"10.1515\/revneuro-2016-0035"},{"key":"key-10.14336\/AD.2024.0986-8","unstructured":"Rajala RV, Rajala A (2024). From Insight to Eyesight: Unveiling the Secrets of the Insulin-Like Growth Factor Axis in Retinal Health. Aging Dis, 15:1994-2002."},{"key":"key-10.14336\/AD.2024.0986-9","doi-asserted-by":"crossref","unstructured":"Rajala A, Rajala RV (2024). Age-Related Changes in the Glycolytic Enzymes of M2-Isoform of Pyruvate Kinase and Fructose-1, 6-Bisphosphate Aldolase: Implications to Age-Related Macular Degeneration. Aging Dis, 15:2271-2283.","DOI":"10.14336\/AD.2024.0077"},{"key":"key-10.14336\/AD.2024.0986-10","doi-asserted-by":"crossref","unstructured":"Golzan SM, Goozee K, Georgevsky D, Avolio A, Chatterjee P, Shen K, et al. (2017). Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer\u2019s disease. Alzheimer's Res Ther, 9:1-9.","DOI":"10.1186\/s13195-017-0239-9"},{"key":"key-10.14336\/AD.2024.0986-11","doi-asserted-by":"crossref","unstructured":"Butt TH, Tobiume M, Re DB, Kariya S (2025). Physical Exercise Counteracts Aging-Associated White Matter Demyelination Causing Cognitive Decline. Aging Dis, 15:2136-2148.","DOI":"10.14336\/AD.2024.0216"},{"key":"key-10.14336\/AD.2024.0986-12","unstructured":"Kumar A, Kim F, Song D-K, Choung JJ (2023). Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders. Aging Dis, 15: 2008-2014."},{"key":"key-10.14336\/AD.2024.0986-13","doi-asserted-by":"crossref","unstructured":"Arruda HS, Neri-Numa IA, Kido LA, J\u00fanior MRM, Pastore GM (2020). Recent advances and possibilities for the use of plant phenolic compounds to manage ageing-related diseases. J Functional Foods, 75:104203.","DOI":"10.1016\/j.jff.2020.104203"},{"key":"key-10.14336\/AD.2024.0986-14","doi-asserted-by":"crossref","unstructured":"Fields E, Vaughan E, Tripu D, Lim I, Shrout K, Conway J, et al. (2021). Gene targeting techniques for Huntington\u2019s disease. Ageing Res Rev, 70:101385.","DOI":"10.1016\/j.arr.2021.101385"},{"key":"key-10.14336\/AD.2024.0986-15","doi-asserted-by":"crossref","unstructured":"Kruminis-Kaszkiel E, Juranek J, Maksymowicz W, Wojtkiewicz J (2018). CRISPR\/Cas9 technology as an emerging tool for targeting amyotrophic lateral sclerosis (ALS). Int J Mol Sci, 19:906.","DOI":"10.3390\/ijms19030906"},{"key":"key-10.14336\/AD.2024.0986-16","doi-asserted-by":"crossref","unstructured":"Safari F, Hatam G, Behbahani AB, Rezaei V, Barekati-Mowahed M, Petramfar P, et al. (2020). CRISPR system: a high-throughput toolbox for research and treatment of Parkinson\u2019s disease. Cell Mol Neurobio, 40:477-493.","DOI":"10.1007\/s10571-019-00761-w"},{"key":"key-10.14336\/AD.2024.0986-17","doi-asserted-by":"crossref","unstructured":"Zhang W, Uyemura R, Zhong K, Guo R, Zhong L (2023). Current Advances and Future Perspectives on Mesenchymal Stem Cell-Derived Extracellular Vesicles in Alzheimer's Disease. Aging Dis, 15: 2015-2027.","DOI":"10.14336\/AD.2023.1206"},{"key":"key-10.14336\/AD.2024.0986-18","doi-asserted-by":"crossref","unstructured":"Akhtar A, Andleeb A, Waris TS, Bazzar M, Moradi A-R, Awan NR, et al. (2021). Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics. J Control Release, 330:1152-1167.","DOI":"10.1016\/j.jconrel.2020.11.021"},{"key":"key-10.14336\/AD.2024.0986-19","doi-asserted-by":"crossref","unstructured":"Cao C, Fu G, Xu R, Li N (2023). Coupling of Alzheimer's Disease Genetic Risk Factors with Viral Susceptibility and Inflammation. Aging Dis, 15: 2028-2050.","DOI":"10.14336\/AD.2023.1017"},{"key":"key-10.14336\/AD.2024.0986-20","unstructured":"Kawano H, Yamada S, Watanabe Y, Ii S, Otani T, Ito H, et al. (2023). Aging and Sex Differences in Brain Volume and Cerebral Blood Flow. Aging Dis, 15: 2216-2229."},{"key":"key-10.14336\/AD.2024.0986-21","unstructured":"Resnick M, Walker KA, Alisch JSR, Gong Z, et al. (2024). Association of Plasma Markers of Alzheimer\u2019s Disease, Neurodegeneration, and Neuroinflammation with the Choroid Plexus Integrity in Aging. Aging Dis, 15: 2230-2240."},{"key":"key-10.14336\/AD.2024.0986-22","doi-asserted-by":"crossref","unstructured":"Song J (2023). Molecular mechanisms of phase separation and amyloidosis of ALS\/FTD-linked FUS and TDP-43. Aging Dis, 15:2084-2112.","DOI":"10.14336\/AD.2023.1118"},{"key":"key-10.14336\/AD.2024.0986-23","doi-asserted-by":"crossref","unstructured":"Rabiller G, Ip Z, Zarrabian S, Zhang H, Sato Y, Yazdan-Shahmorad A, et al. (2023). Type-2 diabetes alters hippocampal neural oscillations and disrupts synchrony between hippocampus and cortex. bioRxiv:2023.2005. 2025.542288.","DOI":"10.1101\/2023.05.25.542288"},{"key":"key-10.14336\/AD.2024.0986-24","doi-asserted-by":"crossref","unstructured":"Di Luca M, Destrebecq F, Kramer S (2021). Future of the aging brain: Bridging the gap between research and policy. Aging Brain, 1:100002.","DOI":"10.1016\/j.nbas.2020.100002"},{"key":"key-10.14336\/AD.2024.0986-25","doi-asserted-by":"crossref","unstructured":"Paulsen JS, Nance M, Kim J-I, Carlozzi NE, Panegyres PK, Erwin C, et al. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Prog Neurobio, 110:2-28.","DOI":"10.1016\/j.pneurobio.2013.08.003"},{"key":"key-10.14336\/AD.2024.0986-26","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Santos ME, Garcia-Arranz M, Andreu EJ, Garc\u00eda-Hern\u00e1ndez AM, L\u00f3pez-Parra M, Villar\u00f3n E, et al. (2022). Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome. Front Immnol, 13:918565.","DOI":"10.3389\/fimmu.2022.918565"},{"key":"key-10.14336\/AD.2024.0986-27","doi-asserted-by":"crossref","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, et al. (2020). The global burden of neurological disorders: translating evidence into policy. The Lancet Neurology, 19:255-265.","DOI":"10.1016\/S1474-4422(19)30411-9"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T18:11:38Z","timestamp":1724868698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2024.0986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2024.0986","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}